easyslots| Puli Pharmaceutical: Vancomycin hydrochloride for injection obtained drug registration approval

News summary

[Puli Pharmaceutical: Vancomycin Hydrochloride for Injection Obtained Drug Registration Approval] Securities Times e Company News, Puli Pharmaceutical (300630) announced on the evening of May 13 that the company recently received a drug registration approval for Vancomycin Hydrochloride for Injection issued by the State Food and Drug Administration, marking that the drug haseasyslotsineasyslots...

Newsletter text

[Puli Pharmaceutical: Vancomycin Hydrochloride for Injection Obtained Drug Registration Approval] Securities Times e Company News, Puli Pharmaceutical (300630) announced on the evening of May 13 that the company recently received a drug registration approval for Vancomycin Hydrochloride for Injection issued by the State Food and Drug Administration, marking that the drug is qualified to be marketed in China. This drug is suitable for intravenous drip for infections caused by methicillin-resistant Staphylococcus aureus and other bacteria.